Vaccine Moderna says it hopes to offer new vaccines for cancer, heart disease, and other conditions by 2030
Tekton Tekton Research Expands Leadership Team with the Addition of Russell Smith as Chief Operating Officer
RSV Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)